The FDA has received 86 adverse event reports for cats that name Afoxolaner.
- 86 reports name Afoxolaner in cats, which is 0.1% of all 151,164 cat reports. A report counts under every active ingredient it names.
- With fewer than 100 reports, percentages are not shown. The counts are below.
- The clinical signs reported most are vomiting, administration error and lethargy.
- The FDA lists 1 approved animal drug application containing Afoxolaner for cats, the earliest approved in 2023.
- None of this is a rate. The FDA data does not record how many cats were given Afoxolaner, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 26 | too few reports to show a share | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 4 | too few reports to show a share | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 10 | too few reports to show a share | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 2 | too few reports to show a share | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 72 | too few reports to show a share | 33% |
Where on the body do the reported signs sit?
Not on the body: Whole body 14% How it was given 10% Did not work 6.8%
- Stomach and gut36%vomiting, not eating, inappetence, diarrhoea and 4 more
- Whole body14%lethargy, lethargy, death
- Behaviour12%hyperactivity, behavioural disorder, vocalisation
- How it was given10%administration error, accidental exposure
- Blood and organ tests7.6%elevated betahydroxybutyrate (bhba), hyperglycaemia, other abnormal test result
- Skin and coat6.8%itching, pruritus
- Did not work6.8%lack of efficacy (ectoparasite) - flea, lack of efficacy
- Heart and breathing4.2%panting
- Brain and nerves3.4%ataxia
Each figure is a share of sign mentions among the 25 signs reported most for Afoxolaner in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting15
- Administration error8
- Lethargy8
- Hyperactivity6
- Not eating6
- Inappetence5
- Itching5
- Lack of efficacy (ectoparasite) - flea5
Reports received per year
Is it approved for cats?
The FDA lists 1 approved animal drug application containing Afoxolaner for cats, the earliest approved in 2023.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| Nexgard ComboBoehringer lngelheim Animal Health USA, Inc. | Topical Solution RX | Cat | 2023 | 141-570 |
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Afoxolaner in dogs (65,969 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.